In vitro activity of RP 59500 (quinupristin dalfopristin) and ramoplanin against vancomycin-resistant Enterococcus faecium

被引:16
作者
Ristow, TA
Noskin, GA
Warren, JR
Peterson, LR
机构
[1] NW MEM HOSP,DEPT MED,DIV INFECT DIS,CHICAGO,IL 60611
[2] NW MEM HOSP,DEPT PATHOL,DIV CLIN MICROBIOL,CHICAGO,IL 60611
[3] NORTHWESTERN UNIV,SCH MED,CHICAGO,IL 60611
来源
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE | 1995年 / 1卷 / 04期
关键词
D O I
10.1089/mdr.1995.1.335
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Vancomycin-resistant Enterococcus faecium (VREF) collected between July 1991 and February 1994 were tested in vitro against RP 59500 and ramoplanin using agar dilution and standard macro broth dilution procedures. Colony counts were determined at 0, 4, and 24 h. RP 59500 had an MIC range of less than or equal to 0.5-8 mu g/ml with an MIC(90) of 2 mu g/ml and a MBC range of less than or equal to 0.5-16 mu g/ml with an MBC(90) of 16 mu g/ml. Ramoplanin had an MIC range of less than or equal to 0.125-1 mu g/ml with an MBC range of less than or equal to 0.125-1 mu g/ml. The MIC(90) for ramoplanin was 1 mu g/ml and the MBC(90) was 4 mu g/ml for the tested isolates, Against these isolates of E. faecium, RP 59500 was bactericidal at 8X MIC, a potentially achievable level using a high drug dosage.(10) Ramoplanin was bactericidal at 2X MIC.
引用
收藏
页码:335 / 339
页数:5
相关论文
共 24 条
[1]  
ANDREWS JM, 1993, 33 INT C ANT AG CHEM
[2]   RP 59500 - A PROPOSED MECHANISM FOR ITS BACTERICIDAL ACTIVITY [J].
AUMERCIER, M ;
BOUHALLAB, S ;
CAPMAU, ML ;
LEGOFFIC, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 :9-14
[3]   RAMOPLANIN SUSCEPTIBILITY TESTING CRITERIA [J].
BARRY, AL ;
PFALLER, MA ;
FUCHS, PC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (07) :1932-1935
[4]  
BERTHAUD N, 1982, 33 INT C ANT AG CHEM
[5]  
CASEWELL MW, 1993, 33 INT C ANT AG CHEM
[6]   INVITRO ACTIVITY OF RP59500, AN INJECTABLE STREPTOGRAMIN ANTIBIOTIC, AGAINST VANCOMYCIN-RESISTANT GRAM-POSITIVE ORGANISMS [J].
COLLINS, LA ;
MALANOSKI, GJ ;
ELIOPOULOS, GM ;
WENNERSTEIN, CB ;
FERRARO, MJ ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (03) :598-601
[7]  
COOPER L, 1995, 34 INT C ANT AG CHEM
[8]   INVITRO EVALUATION OF RAMOPLANIN (MDL-62198,A-16686) [J].
DIXSON, S ;
BRUMFITT, W ;
HAMILTONMILLER, JMT .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (06) :819-821
[9]   INCREASING PROBLEMS IN THE THERAPY OF ENTEROCOCCAL INFECTIONS [J].
ELIOPOULOS, GM .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (06) :409-412
[10]   A PHASE-I, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE TOLERANCE AND PHARMACOKINETIC BEHAVIOR OF RP 59500 [J].
ETIENNE, SD ;
MONTAY, G ;
LELIBOUX, A ;
FRYDMAN, A ;
GARAUD, JJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 :123-131